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ABSTRACT 
Mutations in ERCC2, a Nucleotide Excision Repair (NER) gene leads to Xeroderma pigmentosum (XP), Trichothiodystrophy 
(TTD) and Cockayne Syndrome (CS) phenotypes with various severities. While patients undergo XP disease are primarily 
suffering from skin hypersensitivity but rarely having central nervous system problems, TTD and CS patients are mostly 
having neurological disorders. In addition to that severe changes in hair and nail texture are especially unique to TTD. Hereby 
we report a previously healthy patient developed a rapid neurological decline and severe leukodystrophy due to an acute 
infection in which kept up with mild UV sensitivity and mild developmental delay. Pathophysiology of infection related 
neurodegeneration and DNA repair genes are also discussed. 
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he nucleotide excision repair (NER) pathway, 
includes a minimum number of 28 genes, and 
mainly serves to repair DNA parts that are 
damaged by ultraviolet (UV) radiation in sunlight and also 
has a role in the nervous system [1, 2]. ERCC2 is one of 
the major genes in this pathway that codes instructions for 
production of XPD which is an essential subunit of 
proteins known as the general transcription factor IIH 
(TFIIH) complex. Two major features of TFIIH complex 
are involved in gene transcription in the meanwhile they 
assist in the repairing of damaged DNA [3]. Defected NER 
genes identify several rare clinical diseases such as 
Xeroderma Pigmentosum (XP), Trichothiodystophy (TTD) 
and Cockayne Syndrome (CS) [4, 5].  
XP patients have clinical features such as severe UV 
sensitivity leading to skin cancer. Approximately 30% of 
these patients also have neurological abnormalities such as 
diminished or absent deep tendon reflexes and 
sensorineural hearing loss. Moreover, intellectual capacity 
improves during the postnatal period; however, it could be 
followed by deterioration over years. In addition, MRI 
findings show cerebellar and cerebral atrophy with 
involvement of the white matter. Ventricular enlargement 
may also be seen [6].  
Skin cancer tendency is usually not observed in TTD 
patients, however majority of the patients have UV 
sensitivity. TTD patients also have mental retardation, 
short stature, frequent infections, ichthyosis, 
onychodystrophy and genital abnormalities. Furthermore, 
the MRI findings of those patients primarily demonstrate 
hypomyelination on the cerebral white matter on the other 
hand atrophy of the brain is rarely detected [7-9]. Mutation 
in ERCC2 gene also causes CS which is characterized by 
dysmorphic face with deep-set eyes, protruding ears and 
aged facial appearance. CS patients have postnatal failure 
of brain growth and additionally may have short stature, 
sexual abnormalities and ataxia. In addition to decreased or 
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absent myelination, cerebral atrophy and calcification of 
the basal ganglia are also observed in MRI [10, 11]. 
Hereby we report a patient with mild developmental 
delay and UV sensitivity and leukodystrophic pattern in 
MRI, which was triggered after an acute infection.  
CASE REPORT 
A 3-year-old patient referred to emergency service and 
was hospitalized due to bloody diarrhea. He was born at 
term without any complications from healthy 
consanguineous parents. He walked at 2 years and was 
able to talk with 10-15 words at that age. Fecal 
investigations suggested amebiasis as the cause for bloody 
diarrhea. After recovery, hand tremors followed by 
restlessness occurred. Eventually he lost head control and 
severe ataxia was generated.  On the first examination, he 
had no head control, could not sit unsupported and was 
lacked of eye tracking.  Deep tendon reflexes were brisk. 
He also developed dysarthria and reduced speech.  Routine 
biochemical tests were within normal ranges except 
moderately high cholesterol levels and liver function tests. 
Liver function tests normalized by time; however, 
cholesterol levels remained high. Lysosomal enzymes 
levels and electromyographic studies were all within 
normal ranges.  
Magnetic resonance imaging (MRI) 
and spectroscopy (MRS) of the brain were performed on a 
1.5-T system. Multivoxel MRS was performed by using 
the point-resolved two-dimensional chemical shift imaging 
(CSI) (TR: 1500; TE: 135/35 ms). Voxels were placed in 
deep white matter of frontal and occipital lobes and 
basal ganglions. N-acetylaspartate, choline, creatine, myo-
inositol, lactate and glutamine/glutamate peaks were 
analyzed. Cranial MRI at that time showed diffuse white 
matter demyelination sparing grey zones and brain stem. 
Moreover diffuse dysmyelination with increased T2 
signals was noted throughout the supratentorial white 
matter. At short and long echo MRS, increased 
myoinositol peak correlates with gliosis, increased 
glutamine/glutamate peak correlates with acute excitotoxic 
injury were seen. Elevated lactate levels demonstrated an 
acute response. Choline peaks also made a minimal 
increase (Figure 1).   
According to clinical and MRI findings; DNA was 
extracted from peripheral blood. Amplified PCR samples 
are used for gene libraries by using NEXTERA XT 
(ILLUMINA, USA) kit protocol. All exons and exon 
intron boundaries of five Vanishing White Matter disease 
genes (EIF2B1-EIF2B5) were sequenced on the MiSeq 
platform. No mutation was detected on these five genes. 
On the second step we performed exome sequencing on 
the NextSeq500 platform. Variants were analyzed using 
Variant Studio and pathogenicity was evaluated using 
Alamut and HGMD Pro databases. In order to identify the 
causative gene mutation, exome sequencing revealed a 
homozygous missense change in the ERCC2 gene 
[NM_000400:c.C334T:p.R112C]. This variant was 
previously reported to cause Trichothiodystrophy [12]. 
 
Figure 1: (a) Diffuse dysmyelination throughout 
supratentorial white matter during acute attack, short (b) 
and long echo MRS (c) shows increased myoinositol peak, 
increased glutamine/glutamate peak and increased lactate 
peak. (d) Controlled MRI and MRS performed one year 
later, decrease in T2 signal changes in supratentorial 
white matter, short (e) and long echo MRS (f) shows 
decrease in lactate and glutamine-glutamate peaks, 
unchanged myoinositol and choline peaks. Glu/Glx: 
Glutamine/glutamate. Myo:myoinositol 
Patient’s ataxia and truncal hypotonia recovered within 2 
weeks.  However, after 10 months during summer time, he 
developed severe sunburns over his face which was treated 
with topical cortisone (Figure 2). After genetic diagnosis; 
patient was interned and reevaluated at the age of 46 
months.  The patient had no signs of onychodystrophy, 
brittle hair or facial dimorphisms. The control MRI/MRS 
showed that, dysmyelination signal changes in 
supratentorial white matter had decreased. At short and 
long echo MRS, compared to previous spectra which were 
taken one year ago, marked neither lactate nor glutamine-
glutamate peaks 
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Figure 2a: Patient showing facial lesions after sun 
exposure 2b: Recovery of sunburn after 2 weeks of 
topical cortisone treatment.  
DISCUSSION 
In the last twenty years, studies have shown that XP, 
TTD and CS are in a close relationship even though they 
have phenotypic heterogeneity. Despite highly different 
clinical characteristics of the XP and TTD, these 
syndromes have been shown to overlap in several cases 
[12-15]. Diagnosing cases with ERCC2 gene mutation 
indicates mild phenotypic features which are challenging. 
Presence of relatively occult findings like the absence of 
severe intellectual deficiency, initial UV sensitivity, nail 
dystrophy and facial dysmorphism makes this case 
difficult to name.  The presented patients mostly show 
features that resemble XP-Neurological disease, however, 
in those patients myelin destruction has not been reported 
[13, 16]. This raises two possibilities; lack of a triggering 
effect like an infection in previous XP-Neurological 
patients that may cover up a potential white matter change; 
or the boundaries of NER syndromes are so obscure and 
constitute a wide spectrum of disorders (makes them 
difficult to distinguish compare to distinct diseases) that 
are difficult to distinguish rather than distinct diseases.  
In this case, the patient admitted with complaint of 
acute gastroenteritis which was re-admitted after two 
weeks with symptoms of gait disturbance and the MRI 
images showed destruction of cerebral white matter. The 
association with Leukodystrophy and infection has been a 
popular field of study, however, has never been a well-
known entity. White matter disease that is triggered by a 
minor trauma or infection may be seen in acquired or 
inherited leukodystrophies such as; Multiple Sclerosis and 
Vanishing White Matter (VWM) disease [17, 18]. 
Endoplasmic reticulum (ER) stress is just known to be a 
triggering factor [19]. It was proposed that in case of 
exceeding the capacity of the ER provokes ER stress and 
triggers the unfolded protein response (UPR) that leads to 
the apoptotic death of the stressed cell. The UPR is a 
coordinator for decreasing protein folding load, increasing 
folding capacity of the ER, and inducing cytoprotective 
genes like ERCC2 [20].  
We have identified a homozygous missense mutation 
on exon 5 [NM_000400; 334C>T; p.R112C] in the 
ERCC2 gene. This mutation was previously reported at a 
compound heterozygous state in an 11-year-old boy who 
had an obvious phenotype of TTD. The patient had 
dystrophic hair, diffuse cerebral hypomyelination, 
developmental delay, microcephaly, ichthyosis, cataract 
and recurrent infections. He also had mild, diffuse central 
osteosclerosis [12]. Clinical findings of our patient were 
mild compared to that previous case in the literature. 
White matter change was the only finding in common with 
TTD present in our patient. It could be attributed to the 
young age of the child who is only 46 months of age since 
according to another case-report; onychodystrophy or 
mental retardation may be a late onset feature in TTD [14].  
Our patient had also high cholesterol levels compared 
to his age group. A 27 year-old patient with XP/TTD had 
also high lipid profile [14]. Hypercholesterolemia is not a 
common feature of XP or TTD patients however it is 
reported in other NER disorders such as Ataxia 
Oculomotor Apraxia and Spinocerebellar ataxia with 
axonal neuropathy (SCAN1) [21]. Physicians should be 
aware of high lipid profiles and liver/kidney failures 
beginning from early ages.  
CONCLUSION 
Diagnosing cases with ERCC2 mutation shows mild 
phenotypic features are challenging. Exome sequencing 
allows an earlier diagnosis of mild cases before the 
appearance of clear symptoms. Our patient had an acute 
leukodystrophy as an initial finding however developed 
UV sensitivity after causative mutation was found. Unlike 
TTD, the patient has neither severe intellectual disability 
and onychothiodystrophy nor brittle hair. Besides, he did 
have leukodystrophy, which is not a feature of XP. This 
report is unique as it presents an acute initiation of 
leukodystrophy followed by recovery and development of 
XP neurological phenotype afterwards. We recommend 
physicians to be aware of mild manifestations of ERCC2 
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mutations and to investigate DNA repair genes in 
leukodystrophy before UV sensitivity presents. 
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